KURA
Kura Oncology Inc
10.80$
-0.9%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 86.8% | 99.6% | 98.6% | 98.7% | 99.4% | 99.0% | 98.5% | 97.8% | 97.8% | 96.3% | 98.0% | 96.0% | |
| 81.6% | 17.7% | 13.9% | 11.9% | 8.8% | 10.8% | 50.3% | 17.0% | 11.4% | 8.3% | 29.5% | 20.2% | |
| 81.6% | 98.3% | 97.1% | 97.2% | 98.1% | 97.9% | 97.9% | 97.0% | 96.0% | 94.4% | 95.7% | 90.4% | |
| 2.2% | 0.5% | 0.4% | 0.2% | 0.1% | 0.0% | – | 0.3% | 0.2% | 0.6% | 0.8% | 1.7% | |
| – | – | – | – | – | – | – | – | – | – | 0.0% | 0.1% | |
| 2.0% | 0.1% | 0.1% | 0.0% | – | 0.1% | 0.3% | 0.5% | 0.6% | – | – | – | |
| 349.1% | 5.9% | 18.5% | 16.7% | 11.7% | 9.6% | 5.6% | 5.1% | 7.9% | 11.5% | 45.6% | 76.4% | |
| 218.9% | 5.8% | 7.8% | 10.5% | 7.5% | 6.4% | 4.0% | 4.2% | 5.3% | 7.9% | 10.4% | 15.8% | |
| 147.8% | – | 10.5% | 1.6% | – | 0.2% | 0.8% | 0.4% | 0.5% | 0.3% | 0.6% | 0.2% | |
| 16.4% | 1.1% | 2.0% | 1.3% | 2.2% | 1.5% | 0.4% | 0.6% | 0.3% | 0.5% | 0.2% | 0.7% | |
| 35.8% | 8.4% | 10.5% | 5.8% | 4.1% | 3.0% | 0.7% | – | 2.0% | 2.1% | 0.9% | 1.3% | |
| -249.1% | 94.1% | 81.5% | 83.3% | 88.3% | 90.4% | 94.4% | 94.9% | 92.1% | 88.5% | 54.4% | 23.6% | |
| -266.4% | -30.1% | -77.1% | -93.2% | -82.1% | -88.0% | -46.7% | -81.1% | -124.7% | -160.7% | -117.8% | -159.0% | |
| 297.0% | 11.4% | 26.8% | 24.2% | 19.3% | 17.3% | 8.2% | 12.4% | 14.7% | 16.3% | 11.3% | 11.9% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.